üPfizer is an American multinational pharmaceutical company founded in 1849
üThe latest annual revenue is $51.75 billion
üIt is a well-performing corporation based on the Fortune’s ranking
üIt is position 64, although down from 57 in 2018
üIts productivity rely heavily on patents
üIt is projected to be highly profitable in the next 12 months
üIts ticker is PFE
Performance indicators
üThere was a revenue decrease from $53.6 billion in 2018 to $51.8 billion in 2019
üPfizer’s cash flow from operations was $12.6 billion in 2019
üThe company’s price-to-earnings ratio stands at $12.8
üThe stock dividends was 0.34, 0.36, and 0.38 at the beginning of 2018, 2019, and 2020, respectively
üThe diluted earnings per share ratio is currently $0.39
Performance indicators
| 2017 | $16.8 Billion | $4.7 Billion | $23 Billion |
| 2018 | $15.8 Billion | $4.5 Billions | $20.4 Billion |
| 2019 | $12.6 Billion | $3.9 Billion | $8.5 Billions |
Order an Essay Now & Get These Features For Free:
Turnitin Report
Formatting
Title Page
Citation
Outline
